ZyVersa Therapeutics Inc. (NASDAQ:ZVSA) shares, rose in value on Thursday, 05/25/23, with the stock price down by -5.88% to the previous day’s close as strong demand from buyers drove the stock to $0.41.
Actively observing the price movement in the last trading, the stock closed the session at $0.44, falling within a range of $0.41 and $0.4499. Referring to stock’s 52-week performance, its high was $25.00, and the low was $0.37. On the whole, ZVSA has fluctuated by -17.67% over the past month.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
#####
#####
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ZVSA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
0 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 0 analyst(s), 0 recommend it as a Buy and 0 called the ZVSA stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is -.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ZVSA currently trading nearly -14.78% and -67.41% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.66, while the 7-day volatility ratio is showing 13.19% which for the 30-day chart, stands at 15.22%. Furthermore, ZyVersa Therapeutics Inc. (ZVSA)’s average true range (ATR) is 0.12.
#####
Data on historical trading for ZyVersa Therapeutics Inc. (NASDAQ:ZVSA) indicates that the trading volumes over the past 10 days have averaged 2.73 million and over the past 3 months, they’ve averaged 1.50 million. According to company’s latest data on outstanding shares, there are 9.13 million shares outstanding.
Nearly 54.99% of ZyVersa Therapeutics Inc.’s shares belong to company insiders and institutional investors own 81.20% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.21 million shares as on Apr 27, 2023, resulting in a short ratio of 0.18. According to the data, the short interest in ZyVersa Therapeutics Inc. (ZVSA) stood at 1.04% of shares outstanding as of Apr 27, 2023; the number of short shares registered in Mar 30, 2023 reached 0.2 million. The stock has fallen by -73.89% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZVSA stock heading into the next quarter.
